SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login
  • Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence

    Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence

    People with operable non-small cell lung cancers have a reduced risk of death and disease recurrence if they receive immunotherapy treatments before and after surgery instead of only before surgery, according to a new analysis by Johns Hopkins Kimmel Cancer Center investigators.

    LEARN MORE
    SEE ALL NEWS
    Recent Posts
    American Cancer Society Updates Prostate Cancer Screening Guideline Prostate Cancer: Advancements in Screening Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk Newly Identified Inhibitors May Boost Chemotherapy Drug’s Ability to Fight Treatment-Resistant Cancers Virtual Tumor Predict Response to Liver Cancer Immunotherapy Ovarian Cancer Researcher Wins Prestigious Lotus Award Blocking Energy Metabolism May Help Treat Aggressive Pediatric Brain Tumor This new drug could change how we treat one of the deadliest cancers Inherited Long Telomeres May Drive Broad Risk for Lymphoid Cancers
    Johns Hopkins

    2026 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top